LORAZEPAM | A218597 | GRAVITI PHARMACEUTICALS PRIVATE LTD
Highest NADAC/Unit
$0.0696
per ea
Lowest NADAC/Unit
$0.0329
per ea
Brand NDCs
0
Generic NDCs
6
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 64980062901LORAZEPAM 2 MG TABLET | $0.0696 | EA | Generic | — | 2026-06-17 |
| 64980062950LORAZEPAM 2 MG TABLET | $0.0696 | EA | Generic | — | 2026-06-17 |
| 64980062801LORAZEPAM 1 MG TABLET | $0.0365 | EA | Generic | — | 2026-06-17 |
| 64980062850LORAZEPAM 1 MG TABLET | $0.0365 | EA | Generic | — | 2026-06-17 |
| 64980062701LORAZEPAM 0.5 MG TABLET | $0.0329 | EA | Generic | — | 2026-06-17 |
| 64980062750LORAZEPAM 0.5 MG TABLET | $0.0329 | EA | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.